Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Javitt

Showing results (1-10 of 265) with videos related to

Pageof 27
Sort By:
The American Journal of Psychiatry|March 1, 2025
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?Daniel C Javitt
The American Journal of Managed Care|September 3, 2014
Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: exploring the treatment landscapeDaniel C Javitt
The American Journal of Psychiatry|April 2, 2016
Biotypes in Psychosis: Has the RDoC Era Arrived?Daniel C Javitt
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Glycine modulators in schizophreniaDaniel C Javitt
Trends in Cognitive Sciences|March 26, 2002
Madness in the garden or worm in the apple?Daniel C. Javitt
Biological Psychiatry|February 13, 2018
Excitatory Amino Acids in Schizophrenia: Both What You Have, and What You Do With ThemDaniel C Javitt
Annual Review of Clinical Psychology|March 31, 2009
When doors of perception close: bottom-up models of disrupted cognition in schizophreniaDaniel C Javitt
Annals of the New York Academy of Sciences|February 28, 2015
Neurophysiological models for new treatment development in schizophrenia: early sensory approachesDaniel C Javitt
Current Topics in Behavioral Neurosciences|April 1, 2025
Disturbances in Auditory and Visual Perceptual Function in Schizophrenia: Patterns, Causes, and ConsequencesDaniel C Javitt
Schizophrenia Research. Cognition|November 9, 2017
Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31-July 1, 2014Daniel C Javitt
Pageof 27

Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
The American Journal of Psychiatry|March 1, 2025
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?Daniel C Javitt
The American Journal of Managed Care|September 3, 2014
Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: exploring the treatment landscapeDaniel C Javitt
The American Journal of Psychiatry|April 2, 2016
Biotypes in Psychosis: Has the RDoC Era Arrived?Daniel C Javitt
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Glycine modulators in schizophreniaDaniel C Javitt
Trends in Cognitive Sciences|March 26, 2002
Madness in the garden or worm in the apple?Daniel C. Javitt
Biological Psychiatry|February 13, 2018
Excitatory Amino Acids in Schizophrenia: Both What You Have, and What You Do With ThemDaniel C Javitt
Annual Review of Clinical Psychology|March 31, 2009
When doors of perception close: bottom-up models of disrupted cognition in schizophreniaDaniel C Javitt
Annals of the New York Academy of Sciences|February 28, 2015
Neurophysiological models for new treatment development in schizophrenia: early sensory approachesDaniel C Javitt
Current Topics in Behavioral Neurosciences|April 1, 2025
Disturbances in Auditory and Visual Perceptual Function in Schizophrenia: Patterns, Causes, and ConsequencesDaniel C Javitt
Schizophrenia Research. Cognition|November 9, 2017
Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31-July 1, 2014Daniel C Javitt
Pageof 27